177Lu-DOTATATE peptide receptor radionuclide therapy versus Everolimus in advanced pancreatic neuroendocrine tumors

DNA damage response (DDR) and repair kinetics predict treatment response in patients receiving Lu-177-DOTA-TATE peptide receptor radionuclide therapy for advanced gastro-entero-pancreatic neuroendocrine tumors

10.1055/s-0040-1708134 ◽

2020 ◽

Author(s):

T Derlin ◽

N Bogdanova ◽

F Ohlendorf ◽

R Werner ◽

H Christiansen ◽

...

Keyword(s):

Dna Damage ◽

Treatment Response ◽

Neuroendocrine Tumors ◽

Dna Damage Response ◽

Radionuclide Therapy ◽

Peptide Receptor ◽

Damage Response ◽

Predict Treatment Response

Histopathological and Immunophenotypic Changes of Pancreatic Neuroendocrine Tumors after Neoadjuvant Peptide Receptor Radionuclide Therapy (PRRT)

Endocrine Pathology ◽

10.1007/s12022-020-09623-4 ◽

2020 ◽

Vol 31 (2) ◽

pp. 119-131

Author(s):

Marco Schiavo Lena ◽

Stefano Partelli ◽

Paola Castelli ◽

Valentina Andreasi ◽

Chanel Elisha Smart ◽

...

Keyword(s):

Neuroendocrine Tumors ◽

Radionuclide Therapy ◽

Peptide Receptor Radionuclide Therapy for Pancreatic Neuroendocrine Tumors

Default Digital Object Group ◽

10.1200/adn.19.190464 ◽

2019 ◽

Keyword(s):

Neuroendocrine Tumors ◽

Radionuclide Therapy ◽

Peptide Receptor Radionuclide Therapy and the Treatment of Gastroentero-pancreatic Neuroendocrine Tumors: Current Findings and Future Perspectives

Nuclear Medicine and Molecular Imaging ◽

10.1007/s13139-018-0517-x ◽

2018 ◽

Vol 52 (3) ◽

pp. 190-199 ◽

Cited By ~ 12

Author(s):

Nader Hirmas ◽

Raya Jadaan ◽

Akram Al-Ibraheem

Keyword(s):

Neuroendocrine Tumors ◽

Radionuclide Therapy ◽

Future Perspectives ◽

Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights

OncoTargets and Therapy ◽

10.2147/ott.s202867 ◽

2020 ◽

Vol Volume 13 ◽

pp. 3545-3555 ◽

Cited By ~ 1

Author(s):

Jason S Starr ◽

Mohamad Bassam Sonbol ◽

Timothy J Hobday ◽

Akash Sharma ◽

Ayse Tuba Kendi ◽

...

Keyword(s):

Neuroendocrine Tumors ◽

Radionuclide Therapy ◽

Peptide receptor radionuclide therapy for patients with advanced pancreatic neuroendocrine tumors

Seminars in Oncology ◽

10.1053/j.seminoncol.2018.08.004 ◽

2018 ◽

Vol 45 (4) ◽

pp. 236-248 ◽

Cited By ~ 14

Author(s):

John Ramage ◽

Boris G. Naraev ◽

Thorvardur R. Halfdanarson

Keyword(s):

Neuroendocrine Tumors ◽

Radionuclide Therapy ◽

Dose Response of Pancreatic Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy Using 177Lu-DOTATATE

Journal of Nuclear Medicine ◽

10.2967/jnumed.114.148437 ◽

2015 ◽

Vol 56 (2) ◽

pp. 177-182 ◽

Cited By ~ 68

Author(s):

E. Ilan ◽

M. Sandstrom ◽

C. Wassberg ◽

A. Sundin ◽

U. Garske-Roman ◽

...

Keyword(s):

Neuroendocrine Tumors ◽

Dose Response ◽

Radionuclide Therapy ◽

Resection of the Primary Tumor Followed by Peptide Receptor Radionuclide Therapy as Upfront Strategy for the Treatment of G1–G2 Pancreatic Neuroendocrine Tumors with Unresectable Liver Metastases

Annals of Surgical Oncology ◽

10.1245/s10434-016-5550-3 ◽

2016 ◽

Vol 23 (S5) ◽

pp. 981-989 ◽

Cited By ~ 23

Author(s):

Emilio Bertani ◽

Nicola Fazio ◽

Davide Radice ◽

Claudio Zardini ◽

Chiara Grana ◽

...

Keyword(s):

Liver Metastases ◽

Neuroendocrine Tumors ◽

Primary Tumor ◽

Radionuclide Therapy ◽

Peptide Receptor ◽

Unresectable Liver Metastases

Two Decades of THERANOSTICS in Neuroendocrine Tumors - Past, Presence and Future of Peptide Receptor Radionuclide Therapy (PRRT)

Endocrine Abstracts ◽

10.1530/endoabs.47.oc7 ◽

2016 ◽

Author(s):

Richard Baum

Keyword(s):

Neuroendocrine Tumors ◽

Radionuclide Therapy ◽

Lanreotide depot/autogel before, during, and after peptide receptor radionuclide therapy (PRRT) in advanced neuroendocrine tumors (NETs): Data from the PRELUDE study

Endocrine Abstracts ◽

10.1530/endoabs.60.oc2 ◽

2018 ◽

Author(s):

Vikas Prasad ◽

Raj Srirajaskanthan ◽

Christos Toumpanakis ◽

Chiara Maria Grana ◽

Sergio Baldari ◽

...

Keyword(s):

Neuroendocrine Tumors ◽

Radionuclide Therapy ◽